Ivonescimab: New Cancer Drug Outperforms Global Leader
Breakthrough cancer drug Ivonescimab from a Chinese firm outperformed Keytruda in late-stage trials, sparking global attention in biotech.
My Global News: Voices of a New Era
🌍 Stay Ahead, Stay Global 🚀